Primary Job Title CEO & General Counsel Primary Organization Retham Technologies
Location Milwaukee, Wisconsin, United States Regions Great Lakes, Midwestern US Gender Male
LinkedIn View on LinkedIn
Dr. Sem is also Dean and Professor of Business, Professor of Pharmaceutical Sciences, and Director of Technology Transfer at Concordia University Wisconsin. He also serves on the editorial board of PLoS One Life Sciences, the Board of Directors for the BBB, and for Ozaukee County Economic Development Corp. Dr. Sem has over 20 years of experience in
drug discovery and development and has over 60 papers and 10 issued patents. He co-founded two drug discovery and development companies (Triad and AviMed) and one social venture (Bridge to Cures) before Retham. He served as VP for Biophysics at Triad Therapeutics, where he developed a platform technology for designing focused combinatorial libraries targeting kinases and dehydrogenases. He co-founded Triad Therapeutics based on technology he developed and patented, and he assisted in securing two rounds of venture financing, totaling over $40 million. Triad was voted one of the top 10 biotech startups in the U.S. in 2001 by Drug Discovery Today, and licensed kinase drug leads to Novartis for up to $60 million. Dr. Sem received his B.S. in Chemistry from UW-Milwaukee, his Ph.D. from UW-Madison in Biochemistry, and his MBA and JD degrees from Marquette University.
